Subcutaneous sumatriptan for the treatment of postcraniotomy pain (SUPS trial): protocol for a randomised double-blinded placebo controlled trial

INTRODUCTION: Postcraniotomy pain protocols use opioids, which are considered suboptimal analgesia following this procedure. Multimodal analgesia components are sparse. Our null hypothesis states that sumatriptan is not different to placebo in addition to usual intravenous opioids, for the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Licina, Ana, Russell, Jeremy, Silvers, Andrew, Jin, Xin, Denny, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Anaesthesia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701595/
https://www.ncbi.nlm.nih.gov/pubmed/31427345
http://dx.doi.org/10.1136/bmjopen-2019-032388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701595/
https://www.ncbi.nlm.nih.gov/pubmed/31427345
http://dx.doi.org/10.1136/bmjopen-2019-032388

Ejemplares similares